Stockscreener 앱 받기
88.44
1.34%
-1.20
전일 마감가:
$89.64
열려 있는:
$89.74
하루 거래량:
109.10K
Relative Volume:
0.66
시가총액:
$2.00B
수익:
$213.03M
순이익/손실:
$41.32M
주가수익비율:
48.33
EPS:
1.83
순현금흐름:
$33.49M
1주 성능:
+1.87%
1개월 성능:
+1.21%
6개월 성능:
+6.55%
1년 성능:
-12.88%
1일 변동 폭
$87.73
$89.74
1주일 범위
$85.27
$92.25
52주 변동 폭
$71.42
$109.58
Lemaitre Vascular Inc Stock (LMAT) Company Profile
명칭
Lemaitre Vascular Inc
전화
781-221-2266
주소
63 SECOND AVENUE, BURLINGTON, MA
LMAT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LMAT
Lemaitre Vascular Inc
|
88.44 | 2.03B | 213.03M | 41.32M | 33.49M | 1.83 |
|
ISRG
Intuitive Surgical Inc
|
549.51 | 200.47B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
193.04 | 55.33B | 21.84B | 1.68B | 2.67B | 5.8322 |
|
ALC
Alcon Inc
|
77.65 | 38.61B | 10.19B | 1.05B | 1.39B | 2.1065 |
|
RMD
Resmed Inc
|
244.46 | 36.80B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
261.36 | 19.18B | 2.96B | 487.70M | 344.00M | 6.6758 |
Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-06 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2025-02-28 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2025-02-28 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2025-02-13 | 개시 | Wells Fargo | Equal Weight |
| 2024-10-15 | 개시 | Cantor Fitzgerald | Neutral |
| 2024-08-02 | 재개 | Lake Street | Buy |
| 2024-05-31 | 재개 | ROTH MKM | Buy |
| 2024-04-26 | 업그레이드 | Stifel | Hold → Buy |
| 2024-02-06 | 재개 | KeyBanc Capital Markets | Sector Weight |
| 2023-10-23 | 개시 | JMP Securities | Mkt Outperform |
| 2023-09-06 | 개시 | Oppenheimer | Outperform |
| 2023-08-03 | 다운그레이드 | Jefferies | Buy → Hold |
| 2023-05-03 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2022-10-28 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2021-09-16 | 개시 | Jefferies | Buy |
| 2021-02-12 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2020-03-16 | 업그레이드 | Sidoti | Neutral → Buy |
| 2019-10-24 | 다운그레이드 | First Analysis Sec | Strong Buy → Outperform |
| 2019-10-24 | 업그레이드 | Lake Street | Hold → Buy |
| 2019-10-14 | 업그레이드 | First Analysis Sec | Outperform → Strong Buy |
| 2019-07-25 | 재확인 | Barrington Research | Outperform |
| 2019-07-25 | 업그레이드 | First Analysis Sec | Neutral → Outperform |
| 2018-10-08 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2018-10-08 | 업그레이드 | ROTH Capital | Neutral → Buy |
| 2018-06-08 | 재개 | ROTH Capital | Buy |
| 2018-04-26 | 다운그레이드 | Stifel | Buy → Hold |
| 2018-04-26 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2017-10-27 | 다운그레이드 | First Analysis Sec | Overweight → Equal-Weight |
| 2017-10-27 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2017-07-10 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2017-07-10 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2017-03-21 | 개시 | First Analysis Sec | Overweight |
| 2017-02-22 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2016-09-22 | 다운그레이드 | Sidoti | Buy → Neutral |
| 2016-07-28 | 재확인 | Barrington Research | Outperform |
| 2016-02-25 | 재확인 | Barrington Research | Outperform |
모두보기
Lemaitre Vascular Inc 주식(LMAT)의 최신 뉴스
Using Bollinger Bands to evaluate LeMaitre Vascular Inc.Trade Exit Summary & Risk Controlled Stock Alerts - newser.com
What hedge fund moves indicate for LeMaitre Vascular Inc. (LHU) stockJuly 2025 Institutional & High Accuracy Buy Signal Tips - newser.com
Is LeMaitre Vascular Inc. stock a safe buy before earningsWeekly Stock Summary & Daily Volume Surge Signals - newser.com
Will LeMaitre Vascular Inc. stock remain a Wall Street favoriteDip Buying & Stock Portfolio Risk Management - newser.com
Will LeMaitre Vascular Inc. (LHU) stock announce special dividend2025 Price Targets & Safe Entry Trade Signal Reports - newser.com
Will LeMaitre Vascular Inc. (LHU) stock enhance shareholder value2025 Top Gainers & Stepwise Trade Signal Implementation - newser.com
Will LeMaitre Vascular Inc. stock attract more institutional investors2025 Top Gainers & Step-by-Step Trade Execution Guides - newser.com
Why LeMaitre Vascular Inc. (LHU) stock signals breakout potentialPortfolio Performance Report & Reliable Intraday Trade Plans - newser.com
Will LeMaitre Vascular Inc. stock benefit from green energy trendsQuarterly Profit Summary & Consistent Growth Equity Picks - newser.com
Will earnings trigger a reversal in LeMaitre Vascular Inc.July 2025 Snapshot & Fast Moving Stock Watchlists - newser.com
LeMaitre to Participate in Upcoming Investor Conferences - The Manila Times
LeMaitre (Nasdaq: LMAT) to join Jefferies, Wolfe and Piper Sandler investor conferences - Stock Titan
Will LeMaitre Vascular Inc. (LHU) stock keep high P E multiplesQuarterly Trade Summary & Risk Managed Investment Signals - newser.com
LeMaitre Vascular Experiences Revision in Its Stock Evaluation Amid Competitive Market Dynamics - Markets Mojo
What technical patterns form on LeMaitre Vascular Inc. (LHU) stock chartsTreasury Yields & Real-Time Volume Triggers - newser.com
LeMaitre Vascular stock holds Neutral rating at Cantor Fitzgerald after Q3 results By Investing.com - Investing.com Australia
Is LeMaitre Vascular Inc. stock ready for a breakout2025 Price Momentum & Fast Exit Strategy with Risk Control - newser.com
Applying Elliott Wave Theory to LeMaitre Vascular Inc.2025 Market Trends & Accurate Buy Signal Alerts - newser.com
LeMaitre Vascular stock holds Neutral rating at Cantor Fitzgerald after Q3 results - Investing.com UK
Roth Capital Has Bullish Forecast for LMAT FY2025 Earnings - MarketBeat
Will LeMaitre Vascular Inc. (LHU) stock beat Nasdaq index returnsStop Loss & Weekly Top Gainers Trade List - newser.com
What catalysts could drive LeMaitre Vascular Inc. stock higherPortfolio Value Summary & Verified Swing Trading Watchlist - newser.com
LeMaitre targets 40% Q4 operating income growth and 29% margin as Artegraft expansion accelerates - MSN
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q3 2025 Earnings Call Transcript - Insider Monkey
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Zymeworks (ZYME), MBX Biosciences, Inc. (MBX) and Lemaitre Vascular (LMAT) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Tandem Diabetes Care (TNDM), Lemaitre Vascular (LMAT) and Shattuck Labs (STTK) - The Globe and Mail
LeMaitre Vascular (NASDAQ:LMAT) Price Target Lowered to $93.00 at Wells Fargo & Company - MarketBeat
LeMaitre Vascular, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions - Yahoo Finance
Equities Analysts Offer Predictions for LMAT Q3 Earnings - MarketBeat
LeMaitre Vascular (LMAT) Q3 Earnings Surpass Estimates - sharewise.com
Decoding LeMaitre Vascular Inc (LMAT): A Strategic SWOT Insight - GuruFocus
LeMaitre Vascular (NASDAQ:LMAT) Issues Earnings Results - MarketBeat
LeMaitre Vascular’s Earnings Call: Growth Amid Challenges - TipRanks
Lemaitre Vascular Inc (LMAT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.23%
0.58%
자본화:
|
볼륨(24시간):